Received Jul 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
administered only the liquid component of the Arexvy; administered only the liquid component of the Arexvy; This non-serious case was reported by a physician via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: administered only the liquid component of the Arexvy) and inappropriate dose of vaccine administered (Verbatim: administered only the liquid component of the Arexvy). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 18-JUL-2025 Physician reported that she administered only the liquid component of the Arexvy vaccine to her mother. The patient received only adjuvant of Arexvy, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.